NASDAQ · Financial - Conglomerates
Freenome, Inc. (FRNM) Stock
$15.78
-0.19%
NASDAQ: FRNM
Financial Services
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment
MT Newswires · Jul 27, 2026
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
GlobeNewswire · Jul 27, 2026
Freenome Closes Business Combination With Perceptive Capital Solutions
MT Newswires · Jul 20, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.32%
Institutions Held23.71%
Institutions Float Held23.79%
Peer Comparison
About Freenome, Inc.
Freenome, Inc. is headquartered in US.
Freenome, Inc. (FRNM) stock trades at $15.78 with a market capitalization of $128.72M. The stock is valued at price-to-sales of 31.42. Over the past 52 weeks the stock has ranged between $9.95 and $17.16, and currently trades 8.0% below its 52-week high.
On profitability, Freenome, Inc. generates a return on equity (ROE) of -20.00%, return on capital employed of -3.30%, an operating margin of -1474.30%, a net profit margin of 0.00%.